Cardiometabolic Diseases
22
11
11
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 22 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (22)
Nutrition Counselling for Cardiometabolic Multimorbidity
Qatar Cardiometabolic Cohort
A Study to See How Safe a New Medicine (NNC6022-0001) is in Healthy People
Health Chat for Empowerment-based Lifestyle Planning for Cardiometabolic Multimorbidity
Impact of Circadian Exercise on Metabolic Dysfunction-Associated Steatotic Liver Disease in Postmenopausal Women
Cardiometabolic Disease and Substrate Metabolism
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
Genetic Architecture of Natriuretic Peptides and Blood Pressure Response
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Investigating the Relationship Between Glycemia and Sleep in Adults With Cystic Fibrosis-Related Diabetes
Sustainable Diets and Cardiometabolic Health
Impact of Earplugs on Mechanisms of Noise-Related Cardiovascular Disease
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
Video Vitals and Biomarkers
REal-world Data of CARdiometabolic ProtEcTion
Cardiometabolic Risk Factors and Processed Food
Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study
Preventative Screening and Health Coaching in a Food Insecure Population
Prenatal Programming of Childhood Obesity and Cardio Metabolic Disorders
High Intensity Interval Exercise SCI